1-3 of 3
Vincent A. de Weger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir

Vincent A. de Weger, Frederik E. Stuurman, Stijn L.W. Koolen, Johannes J. Moes, Jeroen J.M.A. Hendrikx, Emilia Sawicki, Bas Thijssen, Marianne Keessen, Hilde Rosing, Marja Mergui-Roelvink, Alwin D.R. Huitema, Bastiaan Nuijen, Jos H. Beijnen, Jan H.M. Schellens, Serena Marchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5466–5474.
https://doi.org/10.1158/1078-0432.CCR-17-2299
Published: 13 September 2019
View article titled, A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir
Open the PDF for A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir in another window
Journal Articles

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy

Annelies W. Turksma, Veerle M.H. Coupé, Marc C. Shamier, Kevin L.H. Lam, Vincent A. de Weger, Jeroen A.M. Belien, Alfons J. van den Eertwegh, Gerrit A. Meijer, Chris J.L.M. Meijer, Erik Hooijberg
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 346–356.
https://doi.org/10.1158/1078-0432.CCR-13-2462
Published: 14 January 2016
View article titled, Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy
Open the PDF for Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy in another window
Journal Articles

Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer

Vincent A. de Weger, Annelies W. Turksma, Quirinus J.M. Voorham, Zelda Euler, Herman Bril, Alfons J. van den Eertwegh, Elisabeth Bloemena, Herbert M. Pinedo, Jan B. Vermorken, Harm van Tinteren, Gerrit A. Meijer, Erik Hooijberg
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 882–889.
https://doi.org/10.1158/1078-0432.CCR-11-1716
Published: 31 January 2012
View article titled, Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer
Open the PDF for Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer in another window
Includes: Supplementary data